FDA — authorised 9 May 2007
- Marketing authorisation holder: UCB INC
- Status: approved
🇺🇸 Neupro in United States
FDA authorised Neupro on 9 May 2007
Marketing authorisations
FDA — authorised 9 May 2007
- Application: NDA021829
- Marketing authorisation holder: UCB INC
- Indication: Type 1 - New Molecular Entity
- Status: approved
Neupro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Neupro approved in United States?
Yes. FDA authorised it on 9 May 2007; FDA authorised it on 9 May 2007.
Who is the marketing authorisation holder for Neupro in United States?
UCB INC holds the US marketing authorisation.